recent
identif
novel
clinic
entiti
sever
acut
respiratori
syndrom
sar
rapid
subsequ
spread
case
fatal
rate
prompt
massiv
intern
collabor
investig
facilit
network
laboratori
establish
world
health
organ
sar
potenti
becom
first
pandem
new
millennium
global
warn
issu
march
diseas
believ
origin
chines
guangdong
provinc
spread
hong
kong
via
intern
airport
current
worldwid
distribut
concert
effort
global
unit
scientif
commun
led
independ
isol
identif
novel
coronaviru
sar
patient
sever
group
extraordinarili
rapid
isol
caus
agent
newli
emerg
infecti
diseas
constitut
unpreced
scientif
achiev
main
scope
articl
provid
clinician
overview
natur
histori
epidemiolog
clinic
characterist
sar
basi
recent
publish
viral
genom
structur
featur
common
member
coronaviru
famili
model
host
cellviru
interact
possibl
target
antivir
drug
present
epidemiolog
consequ
introduc
novel
pathogen
previous
unexpos
popul
origin
evolut
new
pathogen
strain
coronaviru
discuss
fall
first
report
case
highli
contagi
sever
atyp
pneumonia
sever
acut
respiratori
syndrom
sar
see
tabl
case
definit
emerg
guangdong
provinc
southern
china
midfebruari
first
case
found
hong
kong
march
diseas
spread
outsid
china
caus
world
health
organ
issu
global
alert
subsequ
spread
viru
intern
air
travel
led
diseas
outbreak
world
wide
daili
updat
case
count
avail
internet
websit
http
wwwwhoint
present
sar
found
countri
see
fig
total
number
probabl
case
amount
climb
death
toll
current
may
mani
countri
appear
succeed
contain
diseas
prevent
spread
vietnam
first
countri
report
new
case
found
day
three
time
mean
incub
period
thu
remov
vietnam
list
countri
local
transmiss
diseas
china
howev
situat
remain
disturbingli
control
epidemiologist
recent
gain
access
militari
compound
hous
sar
patient
collabor
chines
health
author
tri
establish
procedur
assess
contain
diseas
accord
latest
report
beij
guangdong
provinc
show
number
new
case
may
begun
declin
howev
offici
caution
clear
conclus
sar
outbreak
china
peak
mani
factor
influenc
outbreak
futur
evolut
remain
unknown
exampl
half
new
probabl
case
beij
record
previou
contact
sar
patient
studi
donnelli
et
al
includ
case
present
work
receiv
fund
conflict
interest
hong
kong
investig
key
epidemiolog
determin
spread
sar
viru
infect
onset
onset
admiss
admiss
death
admiss
discharg
mean
incub
period
estim
day
rang
day
mean
time
symptom
onset
hospit
admiss
day
first
case
sar
scandinavia
recent
describ
sweden
finland
view
increas
intern
travel
rate
import
case
undoubtedli
occur
futur
accord
infecti
diseas
depart
copenhagen
univers
hospit
adopt
strict
isol
procedur
high
fever
c
cough
breath
difficulti
one
follow
exposur
day
prior
onset
symptom
close
contact
person
suspect
probabl
case
sar
histori
travel
affect
area
resid
affect
area
person
unexplain
acut
respiratori
ill
result
death
novemb
autopsi
perform
one
follow
exposur
day
prior
onset
symptom
close
contact
person
suspect
probabl
case
sar
histori
travel
affect
area
resid
affect
area
probabl
case
suspect
case
radiograph
evid
infiltr
consist
pneumonia
respiratori
distress
syndrom
rd
chest
xray
cxr
autopsi
find
consist
patholog
rd
without
identifi
caus
exclus
criteria
case
exclud
altern
diagnosi
fulli
explain
ill
present
materi
map
contain
herein
impli
express
opinion
whatsoev
part
world
health
organ
concern
legal
statu
countri
territori
citi
area
author
concern
delimit
frontier
boundari
emerg
respons
plan
contain
potenti
outbreak
devis
implement
secondari
case
sar
report
scandinavia
number
patient
sar
accumul
clinic
featur
diseas
becom
evid
summar
tabl
peiri
et
al
found
fever
pneumonia
initi
respond
treatment
ribavirin
corticosteroid
week
day
patient
subsequ
develop
relaps
fever
radiolog
deterior
wateri
diarrhoea
respiratori
deterior
twenti
per
cent
progress
acut
respiratori
distress
syndrom
ard
third
week
age
hepat
b
statu
found
independ
risk
factor
progress
ard
estim
base
parametr
g
distribut
yield
case
fatal
rate
patient
year
age
respect
assum
nonparametr
method
correspond
rate
overal
case
fatal
rate
concert
effort
global
unit
scientif
commun
led
independ
isol
identif
novel
coronaviru
sar
patient
sever
group
extraordinarili
rapid
isol
caus
agent
newli
emerg
infecti
diseas
constitut
unpreced
scientif
achiev
natur
pathogen
elucid
use
wide
array
techniqu
viru
isol
character
electron
microscopi
revers
transcriptasepolymeras
chain
reaction
serolog
test
clinic
specimen
patient
sar
search
unknown
virus
use
cell
cultur
tabl
clinic
featur
sever
acut
respiratori
syndrom
sar
mean
incub
period
day
vari
day
mean
viraemia
level
peak
day
drop
admiss
level
day
mean
length
hospit
stay
day
common
symptom
summar
follow
fever
temperatur
c
h
chill
andor
rigor
myalgia
cough
andor
headach
dizzi
less
common
symptom
includ
sputum
product
sore
throat
coryza
nauseavomit
diarrhoea
clinic
sign
crackl
auscult
dull
percuss
paraclin
find
lymphopenia
andor
increas
lactat
dehydrogenas
level
thrombocytopenia
prolong
activ
partial
thromboplastin
time
aptt
andor
elev
ddimer
level
less
common
find
includ
increas
level
alanin
aminotransferas
alat
creatin
kinas
well
hypokalaemia
hyponatraemia
serial
chest
xray
may
show
progress
lung
infiltr
pulmonari
ctscan
may
show
groundglass
appear
diffus
patchi
consolid
interstiti
pattern
diagnosi
world
health
organ
criteria
suspect
case
probabl
case
respect
confirm
sought
polymeras
chain
reaction
amplif
sarsrel
coronaviru
relev
specimen
sever
clinic
cours
prognosi
die
develop
ard
increas
age
import
risk
factor
develop
sever
diseas
well
high
mortal
rate
molecular
techniqu
identifi
coronaviru
isol
cell
cultur
sequenc
nucleotid
length
subsequ
obtain
polymeras
chain
reaction
pcr
random
amplif
procedur
basi
obtain
sequenc
convent
realtim
pcr
assay
specif
sensit
detect
novel
viru
establish
subsequ
detect
viru
broad
rang
clinic
specimen
patient
fulfil
clinic
case
definit
control
use
valid
detect
assay
viru
sputum
sampl
abl
infect
exhibit
cytopath
effect
vero
cell
addit
presenc
viru
demonstr
suspens
kidney
tissu
obtain
autopsi
serolog
evid
viru
antibodi
demonstr
serum
faec
obtain
convalesc
phase
find
recent
demonstr
sar
viru
fulfil
koch
postul
lead
conclus
sar
caus
novel
kb
singlestrand
rna
viru
either
alon
coinfect
anoth
infecti
agent
sar
viru
thought
evolv
zoonosi
consequ
chines
agricultur
tradit
mani
type
domest
wild
anim
kept
close
togeth
allow
viral
propag
outsid
natur
host
point
preliminari
studi
implic
number
wild
anim
possibl
natur
reservoir
joint
studi
research
team
hong
kong
shenzhen
china
report
presenc
sever
coronavirus
close
relat
genet
sar
viru
two
anim
speci
test
mask
palm
civet
racoondog
studi
also
found
one
addit
speci
chines
ferret
badger
elicit
antibodi
sar
coronaviru
wild
anim
tradit
consid
delicaci
sold
human
consumpt
market
throughout
southern
china
primari
mode
transmiss
sar
droplet
indirect
direct
contact
present
conclus
evid
suggest
airborn
transmiss
viru
particl
shown
fairli
stabl
remain
infecti
h
dri
plastic
surfac
possibl
day
faec
patient
diarrhoea
find
may
partial
account
observ
cluster
outbreak
amoy
garden
patient
present
diarrhoea
compar
local
outbreak
case
cluster
seem
play
key
role
earli
stage
epidem
possibl
exist
socal
superspread
individu
caus
unusu
larg
amount
secondari
case
subject
specul
would
explain
appar
disproportion
featur
observ
track
diseas
spread
howev
littl
evid
produc
support
hypothesi
viru
detect
high
concentr
sputum
million
molecul
per
millilitr
lower
concentr
blood
faec
acut
convalesc
phase
viral
load
peak
day
decreas
admiss
level
day
clinic
characterist
diseas
likewis
suggest
predilect
respiratori
epithelium
upper
lower
airway
ie
fever
dri
cough
dyspnoea
hypoxia
paraclin
find
includ
air
space
shadow
predominantli
lower
lung
zone
chest
xray
ct
scan
consist
exclud
interstiti
pattern
characterist
find
ct
bilater
peripher
airspac
groundglass
consolid
mimick
bronchiol
obliteran
organ
pneumonia
close
half
case
resolv
pulmonari
infiltr
associ
appear
new
radiolog
lesion
site
histolog
examin
lung
tissu
fatal
case
show
diffus
alveolar
damag
similar
observ
earli
ard
patholog
chang
includ
epitheli
cell
prolifer
presenc
giant
cell
infiltr
increas
pulmonari
macrophag
haemophagocytosi
suggest
cytokin
dysregul
demonstr
subset
patient
tempor
pattern
peak
viraemia
radiolog
deterior
patholog
chang
indic
immunolog
mediat
tissu
damag
may
account
clinic
sever
diseas
coronavirida
consist
two
genera
coronaviru
serogroup
ii
iii
toroviru
contain
human
pathogen
human
corona
viru
frequent
caus
common
cold
present
coryza
cough
gener
malais
numer
biolog
distinct
avian
mammalian
coronavirus
isol
differ
strain
abil
genet
recombin
phylogen
analysi
sar
genom
repres
three
known
group
coronavirus
reveal
protein
encod
sar
viru
cluster
within
three
serogroup
sar
viru
close
relat
group
ii
famili
coronavirus
share
nucleotid
sequenc
homolog
suggest
sar
viru
ascrib
first
repres
possibl
fourth
serogroup
coronaviru
coronavirus
larg
rna
virus
character
distinct
morpholog
fig
replic
strategi
genom
organ
fig
sequenc
homolog
fig
nearli
known
coronavirus
host
specif
although
strain
capabl
cross
speci
barrier
eg
bovin
coronaviru
infect
sever
speci
vitro
vivo
sar
viru
enter
replic
african
green
monkey
kidney
vero
cell
coronavirus
approxim
nm
diamet
consist
host
cellderiv
envelop
nm
complex
surfac
project
surround
peripheri
helic
nucleocapsid
contain
viral
rna
sensestrand
genom
fig
prefix
corona
deriv
crownlik
appear
envelop
protein
seen
electron
microscop
coronavirus
largest
genom
known
rna
virus
kb
genom
encod
rnadepend
rna
polymeras
four
structur
protein
share
coronavirus
structur
protein
includ
three
surfac
glycoprotein
spike
envelop
e
membran
protein
well
capsid
phosphoprotein
n
encapsul
rna
sens
strand
fig
genet
order
polymeras
four
structur
protein
polsemn
fig
surfac
protein
haemagglutinin
esteras
found
certain
strain
serogroup
ii
present
sar
viru
genom
also
encod
number
nonstructur
protein
show
great
variat
differ
strain
coronavirus
function
unknown
essenti
viral
replic
sar
viru
genom
likewis
encod
seven
potenti
nonstructur
protein
show
signific
sequenc
similar
known
protein
preliminari
studi
life
cycl
coronaviru
well
establish
may
serv
model
sar
first
step
viral
life
cycl
coronaviru
consist
bind
virion
plasma
membran
suscept
cell
interact
viral
protein
specif
host
cell
receptor
eg
human
amino
peptidas
receptor
initi
bind
fusion
penetr
uncoat
plusstrand
rna
virus
first
synthesi
follow
entri
translat
viral
genom
rna
yield
rnadepend
rna
polymeras
plusstrand
genom
rna
transcrib
minusstrand
rna
use
templat
synthesi
plusstrand
viral
mrna
genom
rna
first
length
genom
end
approxim
kb
consist
two
overlap
open
read
frame
encod
viral
rnadepend
rna
polymeras
nonstructur
protein
includ
papainlik
proteas
proteas
helicas
ribosom
frameshift
mechan
initi
translat
orfb
larg
polyprotein
subsequ
process
multipl
protein
proteas
cleavag
n
translat
free
polysom
wherea
insert
rough
endoplasm
reticulum
rer
transport
golgiassoci
complex
also
fraction
target
plasma
membran
play
role
cellcel
fusion
brief
format
virion
includ
three
step
bind
nucleocapsid
intracellular
membran
contain
protein
spike
format
incorpor
protein
golgiassoci
compart
time
bud
releas
virion
bud
larg
intracellular
vesicl
sar
molecular
mechan
differ
human
obviou
target
antivir
intervent
increas
knowledg
key
event
replic
cycl
sar
viru
may
thu
facilit
develop
new
antivir
drug
sar
viru
entri
receptor
yet
found
coronavirus
includ
serogroup
coronaviru
enter
target
cell
bind
protein
human
aminopeptidas
n
vitro
bind
inhibit
use
antibodi
solubl
receptor
specif
inhibitor
analog
use
revers
transcriptas
inhibitor
hiv
infect
rnadepend
rna
polymeras
obviou
target
intervent
natur
present
human
cell
ribavirin
rnanucleosid
analogu
effect
case
hepat
c
infect
tri
sarsinfect
individu
howev
effect
clinic
outcom
sar
shown
papainlik
proteas
proteas
helicas
found
coronavirus
also
offer
possibl
target
introduct
sarsspecif
proteas
inhibitor
base
analysi
crystallin
structur
coronaviru
strain
proteas
anand
et
al
propos
avail
rhinoviru
pro
inhibitor
may
modifi
make
use
sar
therapi
attempt
develop
vaccin
coronavirus
human
contrast
commerci
avail
vaccin
base
inactiv
attenu
coronavirus
induc
neutral
antibodi
peripher
blood
immun
anim
provid
limit
protect
diseas
serum
antibodi
n
protein
produc
adult
volunt
respons
inocul
infect
human
coronavirus
infect
adult
volunt
coronaviru
shown
confer
immun
rechalleng
strain
year
later
howev
infect
coronaviru
strain
produc
infect
ill
note
volunt
antibodi
coronavirus
prior
infect
strain
reflect
coronaviru
infect
common
human
sar
previous
infect
human
lack
acquir
immun
may
increas
virul
spread
viru
serum
sarsinfect
survivor
clear
infect
neutral
antibodi
viru
indic
potenti
vaccin
may
effici
unclear
whether
effect
vaccin
sar
made
use
classic
vaccin
method
recombin
protein
inactiv
attenu
virus
whether
cellmedi
respons
necessari
immun
case
search
vaccin
warrant
sar
coronaviru
caus
pulmonari
diseas
human
previou
studi
report
sever
lower
respiratori
diseas
among
frail
elderli
peopl
pneumonia
among
age
group
acut
lower
respiratori
tract
diseas
infant
caus
coronaviru
none
studi
coronaviru
associ
signific
mortal
appar
sar
caus
sever
diseas
children
adult
furthermor
tempor
pattern
clinic
radiolog
progress
time
peak
viraemia
patholog
find
suggest
observ
deterior
second
week
may
immunolog
mediat
tissu
damag
rather
uncontrol
viral
replic
find
led
inclus
corticosteroid
experiment
protocol
prove
benefici
certain
case
ard
could
specul
whether
damag
inflict
sar
could
caus
advers
human
immun
respons
therebi
make
infect
young
age
advantag
distinguish
featur
sar
viru
may
abil
elicit
advers
immun
reaction
theori
spur
effort
character
known
immunogen
epitop
like
protein
intensifi
search
possibl
new
antigen
encod
sar
viral
genom
present
imposs
forecast
whether
continu
effort
contain
erad
sar
succeed
howev
swift
reaction
global
unit
scientif
commun
secur
rapid
identif
character
pathogen
caus
sar
provid
essenti
diagnost
tool
stagger
pace
exist
bodi
knowledg
coronavirus
present
scientist
multitud
potenti
target
medic
intervent
addit
strategi
contain
outlin
prove
effect
industri
well
third
world
set
question
remain
whether
diseas
far
advanc
china
contain
upcom
season
dengu
influenza
viru
bound
interfer
rather
vagu
clinic
case
definit
may
render
present
strategi
contain
inadequ
exceed
capac
chines
healthcar
system
coronavirus
epidem
natur
sar
erad
similar
pattern
cyclic
outbreak
may
anticip
numer
exampl
epidemiolog
consequ
introduc
novel
pathogen
previous
unexpos
popul
sar
becom
endem
develop
immun
affect
popul
may
eventu
decreas
mortal
howev
number
discomfort
characterist
new
pathogen
notabl
except
acquir
immun
defici
syndrom
major
emerg
infecti
diseas
sinc
exhibit
featur
limit
capac
pose
major
threat
intern
public
health
eg
west
nile
fever
requir
mosquito
vector
creutzfeldtjakob
diseas
depend
food
vehicl
transmiss
ebolamarburg
virus
render
host
visibl
ill
unwel
travel
howev
distinguish
featur
sar
appear
absenc
factor
limit
diseas
spread
consequ
sar
gain
foothold
dens
popul
countri
poor
infrastructur
like
india
area
immunocompromis
popul
seen
subsaharan
africa
could
thu
grave
